Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Modular Medical (NASDAQ:MODD) announced it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement.

Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement. As of April 14, 2026, the company evidenced a closing bid price above $1.00 for 10 consecutive trading days, satisfying Nasdaq Marketplace Rule 5550(a)(2).

Nasdaq has advised that the matter is considered closed.

Positive

• Regained Nasdaq compliance as of April 14, 2026 after meeting the minimum bid-price test
• Nasdaq considers the matter closed, removing immediate delisting risk tied to the prior deficiency

Negative

• None.

Argus Apr 16 session

+2.99% close to close Open Argus

Details

News Market Reaction – MODD

On Apr 16, the day this news came out, MODD closed 2.99% above the previous close.

Data tracked by StockTitan Argus for the Apr 16 session.

Key Figures

Minimum bid price: $1.00 Compliance window: 10 consecutive trading days Closing bid threshold date: April 14, 2026

Minimum bid price

$1.00

Nasdaq Capital Market continued listing requirement

Compliance window

10 consecutive trading days

Period with closing bid above $1.00 as of April 14, 2026

Closing bid threshold date

April 14, 2026

Date on which 10th qualifying trading day was achieved

Historical Context

5 past events · Latest: Apr 09

5 events

1. Apr 09

   Regulatory clearance

   24h Move

   -1.6%

   FDA 510(k) clearance for Pivot tubeless insulin patch pump enabling U.S. sales.

2. Mar 26

   Reverse stock split

   24h Move

   -9.8%

   1-for-30 reverse split to increase share price to meet Nasdaq bid rule.

3. Mar 03

   Equity offering

   24h Move

   +7.0%

   Public offering of shares and warrants raising about $12.0M gross proceeds.

4. Feb 04

   Operational milestone

   24h Move

   -4.4%

   Start of validation production lots for Pivot patch pump components.

5. Dec 31

   Nasdaq extension

   24h Move

   +0.6%

   180-day extension to regain compliance with Nasdaq minimum bid price rule.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nasdaq capital market, minimum bid price, nasdaq marketplace rule 5550(a)(2)

3 terms

nasdaq capital market regulatory

"compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

minimum bid price regulatory

"compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement"

The minimum bid price is the lowest share price that a market, regulator, or specific offering will accept for a trade, listing, or auction—think of it as a reserve or floor that a stock must meet to qualify for certain actions. It matters to investors because falling below that floor can limit trading options, trigger compliance measures or delisting risks, and affect liquidity and the perceived value of a holding, much like a reserve price in an auction sets the baseline for a sale.

nasdaq marketplace rule 5550(a)(2) regulatory

"The Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2)"

Nasdaq Marketplace Rule 5550(a)(2) sets a minimum share price requirement for companies listed on the Nasdaq Capital Market, typically requiring that a company’s common stock maintain a closing bid of at least $1.00 per share. It matters to investors because failure to meet this threshold can trigger a delisting review, which is similar to failing a safety inspection: the stock may be removed from the exchange or force corporate actions (like a reverse split) that change liquidity, visibility, and how easy it is to buy or sell the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced that it has received a letter from the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it has regained compliance with the Nasdaq Capital Market's minimum bid price continued listing requirement. The letter noted that, as of April 14, 2026, the Company evidenced a closing bid price of its common stock in excess of the $1.00 minimum requirement for the last 10 consecutive trading days. Accordingly, the Company has regained compliance with Nasdaq Marketplace Rule 5550(a)(2) and Nasdaq considers the matter closed.

About Modular Medical

Modular Medical, Inc. (Nasdaq:MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com

SOURCE: Modular Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Modular Medical (MODD) regaining Nasdaq compliance mean for shareholders?

It means the company has avoided immediate delisting risk by meeting the minimum bid requirement. According to the company, Nasdaq confirmed MODD closed above $1.00 for 10 consecutive trading days, and Nasdaq considers the matter closed.

When did Modular Medical (MODD) regain compliance with Nasdaq's minimum bid rule?

Modular Medical regained compliance effective April 14, 2026 based on recent share prices. According to the company, the stock evidenced a closing bid above $1.00 for 10 consecutive trading days ending April 14, 2026.

How did Modular Medical (MODD) meet the Nasdaq minimum bid-price requirement?

The company met the standard by recording closing bids above the $1.00 threshold for 10 consecutive trading days. According to the company, those closing prices satisfied Nasdaq Marketplace Rule 5550(a)(2).

Has Nasdaq closed the review of Modular Medical (MODD)'s listing status?

Yes; Nasdaq has indicated the matter is closed after the company met the bid-price test. According to the company, Nasdaq notified Modular Medical that compliance was regained and the review is concluded.

What could cause Modular Medical (MODD) to lose Nasdaq compliance again?

Loss of compliance would occur if the stock fails to maintain the minimum bid-price requirement over the required period. According to the company, the test requires closing bids above $1.00 for 10 consecutive trading days.